Global Self-Expanding Stents Market - Key Trends & Drivers Summarized
Why Is The Demand For Self-Expanding Stents Growing In Cardiovascular And Peripheral Procedures?
Self-expanding stents have become a cornerstone in interventional cardiology and vascular procedures due to their ability to improve blood flow in patients with narrowed or blocked arteries. Unlike balloon-expandable stents, which require external pressure to open, self-expanding stents expand automatically upon deployment, offering greater flexibility and adaptability to vessel movement. The rising prevalence of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD), is fueling the need for advanced stent technologies. Additionally, the increasing number of minimally invasive procedures is driving demand for self-expanding stents, as they reduce recovery time, lower complication risks, and improve long-term patient outcomes.What Technological Innovations Are Enhancing The Effectiveness Of Self-Expanding Stents?
Advancements in biomaterials and drug-eluting coatings are significantly improving the performance and safety of self-expanding stents. Nitinol (nickel-titanium alloy) stents are becoming the preferred choice due to their superelasticity and resistance to deformation. Drug-eluting stents (DES), which release antiproliferative drugs, are reducing the risk of restenosis (re-narrowing of arteries), ensuring long-term patency. Additionally, bioresorbable stents, which gradually dissolve in the body after healing the artery, are emerging as a promising alternative to permanent implants. Robotic-assisted stent placement and AI-powered imaging are enhancing precision in stent deployment, improving clinical success rates.Which Healthcare Sectors Are Driving The Demand For Self-Expanding Stents?
Hospitals and cardiac catheterization labs are the primary end-users of self-expanding stents, as they are widely used in angioplasty procedures. Ambulatory surgical centers (ASCs) are also witnessing increased adoption of self-expanding stents due to the shift toward outpatient cardiovascular interventions. The geriatric population, which is at higher risk for vascular diseases, is contributing to the growing demand for stent-based treatments. Additionally, advancements in reimbursement policies and healthcare infrastructure in emerging markets are making self-expanding stent procedures more accessible.What Factors Are Fueling The Growth Of The Self-Expanding Stents Market?
The growth in the self-expanding stents market is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and continuous innovation in stent materials and drug coatings. Regulatory approvals for next-generation stents and expanded healthcare access in developing regions are further boosting market expansion. Additionally, growing awareness of preventive cardiology and advancements in imaging technologies are enhancing patient screening and early intervention. As the demand for safer and more effective vascular treatments continues to rise, the self-expanding stents market is poised for sustained growth.Report Scope
The report analyzes the Self-Expanding Stents market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Product Type (Carotid Self-Expanding Stents, Gastrointestinal Self-Expanding Stents, Endovascular Self-Expandable Stents, Others); Application (Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Carotid Self-Expanding Stents segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 2.9%. The Gastrointestinal Self-Expanding Stents segment is also set to grow at 2.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $989.1 Million in 2024, and China, forecasted to grow at an impressive 3.0% CAGR to reach $728.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Self-Expanding Stents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Self-Expanding Stents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Self-Expanding Stents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, Alvimedica, amg International GmbH, Andramed GmbH, Balton Sp. z o.o. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 34 Featured):
- Abbott Laboratories
- Alvimedica
- amg International GmbH
- Andramed GmbH
- Balton Sp. z o.o.
- Becton, Dickinson and Company (BD)
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Cordis
- Elixir Medical Corporation
- Endologix LLC
- Eucatech AG
- Hexacath
- InspireMD
- Jotec GmbH
- Lifetech Scientific Corporation
- Medinol Ltd.
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Optimed Medizinische Instrumente GmbH
- Rontis Corporation
- Sahajanand Medical Technologies
- Stryker Corporation
- Terumo Corporation
- Translumina GmbH
- Vesalio
- W. L. Gore & Associates
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Self-Expanding Stents - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
3. MARKET TRENDS & DRIVERS
- Increasing Prevalence of Cardiovascular Diseases Drives Demand for Self-Expanding Stents in Vascular Treatments
- Surge in Minimally Invasive Procedures Expands Market Opportunity for Self-Expanding Stents
- Technological Advancements in Biocompatible and Durable Materials Propel Growth in Self-Expanding Stents
- Rising Adoption of Endovascular Surgery Strengthens the Business Case for Self-Expanding Stents in Peripheral and Coronary Artery Treatment
- Growing Focus on Reducing Post-Operative Complications Drives Adoption of Self-Expanding Stents in Various Vascular Procedures
- Increased Investment in Healthcare Infrastructure, Especially in Emerging Markets, Expands Addressable Market for Self-Expanding Stents
- The Shift Toward Personalized Medicine and Tailored Treatments Expands Opportunities for Customizable Self-Expanding Stents
- Surge in Elderly Population and Age-Related Health Conditions Strengthens the Demand for Self-Expanding Stents
- Increasing Demand for Non-Invasive Treatment Options and Quick Recovery Drives Growth in the Self-Expanding Stents Market
- Rise in Consumer Awareness of Cardiovascular Health Drives Adoption of Self-Expanding Stents as a Preferred Treatment Solution
- Stronger Regulatory Approvals and Clinical Evidence on the Efficacy of Self-Expanding Stents Accelerates Market Growth
- TABLE 1: World Self-Expanding Stents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Self-Expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Carotid Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Carotid Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Carotid Self-Expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Gastrointestinal Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Gastrointestinal Self-Expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Gastrointestinal Self-Expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Endovascular Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Endovascular Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Endovascular Self-Expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Fem-Pop Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Fem-Pop Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Fem-Pop Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Iliac Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Carotid Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Biliary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Biliary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Biliary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- UNITED STATES
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- CANADA
- JAPAN
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- CHINA
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- EUROPE
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- FRANCE
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- GERMANY
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- ITALY
- UNITED KINGDOM
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- REST OF EUROPE
- ASIA-PACIFIC
- Self-Expanding Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Alvimedica
- amg International GmbH
- Andramed GmbH
- Balton Sp. z o.o.
- Becton, Dickinson and Company (BD)
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Cordis
- Elixir Medical Corporation
- Endologix LLC
- Eucatech AG
- Hexacath
- InspireMD
- Jotec GmbH
- Lifetech Scientific Corporation
- Medinol Ltd.
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Optimed Medizinische Instrumente GmbH
- Rontis Corporation
- Sahajanand Medical Technologies
- Stryker Corporation
- Terumo Corporation
- Translumina GmbH
- Vesalio
- W. L. Gore & Associates
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 64 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 3.8 Billion |
Forecasted Market Value ( USD | $ 4.5 Billion |
Compound Annual Growth Rate | 3.0% |
Regions Covered | Global |